Worldwide Clinical Trials appoints Evelyn Graham
To lead sales, marketing and business development for late-stage business
With more than 20 years of drug development experience, Graham will lead sales, marketing and business development strategies for the late stage business.
Graham was formerly chief executive of TorreyPines Therapeutics and led the company’s merger with Raptor Pharmaceuticals in September 2009.
You may also like
Research & Development
![Adragos signs agreement with Towa Pharmaceutical to supply off-patent medicines]()
Adragos signs agreement with Towa Pharmaceutical to supply off-patent medicines
Adragos Pharma Kawagoe KK has announced the signing of an agreement with Towa Pharmaceutical Co., Ltd, to establish a strategic collaboration aimed at ensuring the stable supply of off-patent pharmaceuticals
Research & Development
![PharmNovo reports broader therapeutic potential for PN6047]()
PharmNovo reports broader therapeutic potential for PN6047
PharmNovo AB has announced new preclinical findings supporting the potential of PN6047 in migraine and opioid withdrawal syndrome. The findings were generated through the company's NIDA-funded collaboration with researchers at Washington University School of Medicine
You need to be a subscriber to read this article.
Click here to find out more.
Click here to find out more.
Research & Development
![Neuropsychiatric medicine reaches an inflexion point: regulation, science and the road to commercial reality]()
Neuropsychiatric medicine reaches an inflexion point: regulation, science and the road to commercial reality
Shaped by accelerating regulatory support, expanding clinical evidence and growing institutional acceptance, psychedelic medicine is entering a pivotal phase, reports Joel Latham, Chief Executive Officer, President and Director at Incannex Healthcare Inc.
